CRISPR THERAPEUTICS AG's ticker is CRSP and the CUSIP is H17182108. A total of 380 filers reported holding CRISPR THERAPEUTICS AG in Q1 2023. The put-call ratio across all filers is 1.09 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2024 | $37,480,673 | +397.8% | 693,958 | +528.2% | 0.01% | +266.7% |
| Q1 2024 | $7,529,294 | +25.4% | 110,465 | +15.1% | 0.00% | +50.0% |
| Q4 2023 | $6,006,470 | +42.1% | 95,950 | +3.0% | 0.00% | 0.0% |
| Q3 2023 | $4,226,945 | +13.6% | 93,125 | +13.2% | 0.00% | 0.0% |
| Q2 2023 | $3,721,796 | 0.0% | 82,286 | 0.0% | 0.00% | 0.0% |
| Q1 2023 | $3,721,796 | +20.6% | 82,286 | +8.4% | 0.00% | 0.0% |
| Q4 2022 | $3,085,579 | -99.9% | 75,906 | +0.2% | 0.00% | -33.3% |
| Q3 2022 | $4,952,615,000 | -38.8% | 75,786 | -43.1% | 0.00% | -25.0% |
| Q2 2022 | $8,091,770,000 | +8.0% | 133,154 | +11.6% | 0.00% | +33.3% |
| Q1 2022 | $7,490,156,000 | -17.3% | 119,327 | -0.2% | 0.00% | 0.0% |
| Q4 2021 | $9,058,212,000 | -29.3% | 119,533 | +4.5% | 0.00% | -40.0% |
| Q3 2021 | $12,807,032,000 | -32.5% | 114,420 | -2.4% | 0.01% | -37.5% |
| Q2 2021 | $18,975,612,000 | +10.4% | 117,213 | -16.9% | 0.01% | 0.0% |
| Q1 2021 | $17,187,429,000 | +5.2% | 141,054 | +32.1% | 0.01% | 0.0% |
| Q4 2020 | $16,343,881,000 | +62.0% | 106,746 | -11.5% | 0.01% | +60.0% |
| Q3 2020 | $10,086,316,000 | -1.3% | 120,592 | -13.3% | 0.01% | -16.7% |
| Q2 2020 | $10,217,314,000 | +84.9% | 139,030 | +6.7% | 0.01% | +50.0% |
| Q1 2020 | $5,527,211,000 | – | 130,328 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Versant Venture Management, LLC | 508,558 | $82,330,000 | 27.28% |
| Valiant Capital Management, L.P. | 307,700 | $49,814,000 | 3.74% |
| NEA Management Company, LLC | 1,590,002 | $257,405,000 | 3.35% |
| NIA IMPACT ADVISORS, LLC | 39,891 | $6,458,000 | 3.15% |
| Ikarian Capital, LLC | 200,000 | $32,379,000 | 2.62% |
| Soleus Capital Management, L.P. | 103,114 | $16,693,000 | 2.57% |
| HIMENSION CAPITAL (SINGAPORE) PTE. LTD. | 157,334 | $25,471,000 | 2.47% |
| Capital Impact Advisors, LLC | 45,440 | $7,356,000 | 2.37% |
| ARK Investment Management | 7,776,119 | $1,258,876,000 | 2.34% |
| Sassicaia Capital Advisers LLC | 13,513 | $2,188,000 | 2.28% |